Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration (FERTIGO®)

I

Instituto Valenciano de Infertilidad, IVI VALENCIA

Status

Completed

Conditions

Infertility, Female

Treatments

Device: IMAGE CAPTURE SESSION

Study type

Observational

Funder types

Other

Identifiers

NCT05440019
2010-VLC-086-FC

Details and patient eligibility

About

We have developed a new minimally invasive system for endometrial dating, that allows the physician to monitor, capture, project and analyze the actual morphology and maturity of the endometrial surface, at any given time. A time series of such indications provides an assessment regarding the pace of development by which the endometrium is maturing during a relevant cycle. FERTIGO®'s method for endometrial dating has been validated in swine and ex-vivo human samples, where image analysis of tissues has been compared with traditional endometrial dating techniques. The comparison yielded calibration means and correlation between FERTIGO®'s dating and the traditional dating methods. Thus, M3T FERTIGO®'s system is designed to enable the determination of the actual physiological cycle date, in good correlation with the indirect (endometrial thickness and hormones level) and delayed known methods (histopathology). To this end, a high quality, low magnification (X2-X4) image of the endometrium surface should be acquired, stored and analyzed. This trial will evaluate, on the one hand, the safety and usability of the FERTIGO® device and, on the other hand, calibrate it by evaluating image quality. Both safety and usability will be measured through questionnaires answered by the participants (adverse events and satisfaction) and by the physicians (satisfaction), respectively, considering the introduction of the device, its use, and its removal.

Enrollment

20 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1. Healthy women 2. Age: 18 - 40, both inclusive 3. Regular menstrual cycles

Exclusion criteria

1. Simultaneous participation in another clinical study that, at researcher's criteria, could interfere with the results of this study 2. Current pregnancy 3. Women with known existing endometrial pathology 4. Women with known oligo-ovulation or un-ovulation. 5. Women who were diagnosed with Endometriosis or Adenomyosis 6. Women with medical history of malignant tumors in their reproductive system 7. Women with IUD in place 8. Women menstruating on the day of the procedure 9. Women who have signs and symptoms of PID 10. Women who currently use any hormonal medications.

Trial design

20 participants in 1 patient group

HEALTHY WOMEN IVI VALENCIA
Description:
Participants will be exposed to four sessions of image captures using FERTIGO® device. Prior to the session, a vaginal ultrasound (US) will be performed, for measuring the endometrial thickness as in the usual practice.
Treatment:
Device: IMAGE CAPTURE SESSION

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems